V Wealth Advisors LLC Abb Vie Inc. Transaction History

V Wealth Advisors LLC

$123 Million
Q3 2023

A detailed history of V Wealth Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, V Wealth Advisors LLC holds 2,937 shares of ABBV stock, worth $537,705. This represents 0.36% of its overall portfolio holdings.

Number of Shares

2,937

Previous 14,543 79.8%

Holding current value

$537,705

Previous $1.96 Million 77.69%

% of portfolio

0.36%

Previous 0.34%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$133.59 - $154.65 $1.55 Million - $1.79 Million	-11,606 Reduced 79.8%	2,937 $437,000
Q2 2023 Aug 11, 2023	SELL	$132.51 - $164.9 $120,186 - $149,564	-907 Reduced 5.87%	14,543 $1.96 Million
Q1 2023 May 02, 2023	BUY	$144.61 - $166.54 $137,234 - $158,046	949 Added 6.54%	15,450 $2.46 Million
Q4 2022 Jan 20, 2023	BUY	$138.31 - $165.87 $77,730 - $93,218	562 Added 4.03%	14,501 $0
Q3 2022 Nov 04, 2022	SELL	$134.21 - $153.93 $26,439 - $30,324	-197 Reduced 1.39%	13,939 $1.87 Million
Q2 2022 Jul 27, 2022	BUY	$137.62 - $174.96 $74,314 - $94,478	540 Added 3.97%	14,136 $2.17 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $171,310 - $212,547	-1,298 Reduced 8.71%	13,596 $2.2 Million
Q4 2021 Feb 17, 2022	SELL	$107.43 - $135.93 $7,842 - $9,922	-73 Reduced 0.49%	14,894 $2.02 Million
Q3 2021 Oct 21, 2021	SELL	$106.4 - $120.78 $26,174 - $29,711	-246 Reduced 1.62%	14,967 $1.61 Million
Q2 2021 Jul 27, 2021	SELL	$105.21 - $117.21 $167,283 - $186,363	-1,590 Reduced 9.46%	15,213 $1.72 Million
Q1 2021 Apr 20, 2021	BUY	$102.3 - $112.62 $132,580 - $145,955	1,296 Added 8.36%	16,803 $1.82 Million
Q4 2020 Jan 25, 2021	BUY	$80.49 - $108.67 $890,219 - $1.2 Million	11,060 Added 248.71%	15,507 $1.66 Million
Q3 2020 Oct 13, 2020	SELL	$85.91 - $100.83 $830,062 - $974,219	-9,662 Reduced 68.48%	4,447 $390,000
Q2 2020 Jul 29, 2020	BUY	$73.37 - $98.18 $128,617 - $172,109	1,753 Added 14.19%	14,109 $1.39 Million
Q1 2020 May 12, 2020	BUY	$64.5 - $97.79 $174,343 - $264,326	2,703 Added 28.0%	12,356 $941,000
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $155,812 - $187,331	2,474 Added 34.46%	9,653 $731,000
Q2 2019 Jul 29, 2019	BUY	$65.7 - $83.98 $12,023 - $15,368	183 Added 2.62%	7,179 $516,000
Q1 2019 May 16, 2019	BUY	$77.14 - $90.79 $66,108 - $77,807	857 Added 13.96%	6,996 $553,000
Q4 2018 Jan 24, 2019	BUY	$77.85 - $96.01 $14,324 - $17,665	184 Added 3.09%	6,139 $557,000
Q3 2018 Oct 31, 2018	BUY	$88.91 - $98.84 $4,000 - $4,447	45 Added 0.76%	5,955 $563,000
Q2 2018 Jul 16, 2018	BUY	$89.78 - $106.23 $538 - $637	6 Added 0.1%	5,910 $585,000
Q1 2018 Apr 11, 2018	BUY	$92.01 - $123.21 $185,124 - $247,898	2,012 Added 51.7%	5,904 $541,000
Q4 2017 Jan 19, 2018	BUY	$89.56 - $98.21 $68,244 - $74,836	762 Added 24.35%	3,892 $399,000
Q3 2017 Oct 12, 2017	BUY	$69.85 - $89.22 $218,630 - $279,258	3,130	3,130 $277,000

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $324B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of V Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on V Wealth Advisors LLC with notifications on news.

Account

V Wealth Advisors LLC Abb Vie Inc. Transaction History